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A R T I C L E  I N F O A B S T R A C T
Article type:Original article Objective(s): Pseudomonas aeruginosa is one of the most important nosocomial pathogens causing a high rate of mortality among hospitalized patients. Herein, we report the prevalence of antibiotic 
resistance genes, class 1 integrons, major virulence genes and clonal relationship among multidrug- resistant (MDR) P. aeruginosa, isolated from four referral hospitals in the southeast of Iran.
Materials and Methods: In this study, 208 isolates of P. aeruginosa were collected from four referral 
hospitals in southeast of Iran. Disk diffusion method was used to determine susceptibility to 13 
antibacterial agents. AmpC was detected by phenotypic method and β-lactamase genes, virulence 
genes and class 1 integrons were detected by PCR. Clonal relationship of the isolates was determined by RAPD-PCR.
Results: All the isolates were susceptible to polymyxin-B and colistin. Overall, 40.4% of the isolates were MDR, among which resistance to third generation cephalosporins, aminoglycosides, and carbapenems was 47.5%, 32.3% and 40%, respectively. None of the isolates was positive for blaNDM-1 genes, while 84.5% and 4.8% were positive for the blaIMP-1 and blaVIM, metallo-β-lactamase genes, 
respectively. Incidence of class 1 integrons was 95% and AmpC was detected in 33% of the isolates. Prevalence of exoA, exoS, exoU, pilB and nan1 were 98.8%, 44%, 26%, 8.3% and 33.3%, respectively. 
RAPD profiles identified four large clusters consisting of 77 isolates, and two small clusters and three singletons.
Conclusion: : The rate of MDR P. aeruginosa isolates was high in different hospitals in this region. High genetic similarity among MDR isolates suggests cross-acquisition of infection in the region.
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Introduction
Pseudomonas aeruginosa is a Gram-negative opportunistic pathogen and a common source of infections in hospitals, particularly in intensive care 
units (ICUs), where the organism infects 10-15% of the patients. Rapid increase of multidrug-resistant 
P. aeruginosa (MDRPA) isolates in clinical settings 
worldwide has resulted in increased mortality rate (1, 2). Several mechanisms are involved in P. aeruginosa 
resistance to antimicrobial agents such as β-lactamase 
production, target mutation, efflux pumps over-expression, decrease in membrane permeability and chromosomal expression of resistance encoding genes (3). Due to the pressure caused by the overuse 
of β-lactam antibiotics in the hospitals, various forms 
of β-lactamases such as the extended spectrum β- 
lactamases (ESBLs), AmpC and metallo-β-lactamases (MBLs) have evolved (4). Integrons are also important factors in dissemination of antibacterial resistance among different bacterial species and the association 
between integrons and drug resistance has been shown (5). Among the integron classes, class 1 integrons (int1) was the most prevalent among clinical isolates of P. aeruginosa in Ahvaz, Iran (6). In addition to antibiotic resistance, P. aeruginosa produces various virulence factors contributing to pathogenicity of the microorganism. Among these virulence factors are a variety of secreted proteins such as proteases, phospholipases, and exotoxin A (7). In addition, exoenzyme S is a virulence factor encoded by the exoS gene. It is an ADP ribosyltransferase secreted by a type-III secretion system (TTSS), delivered directly into the cytosol of epithelial cells. Another protein, exotoxin U (ExoU), is a necrotizing toxin with phospholipase activity, unique cytotoxic effect, capable of destroying cellular monolayers during short infection periods and plays a role in the development of septic shock (8). In some P. 
aeruginosa hospital isolates, a gene called nan1 encodes an extracellular neuraminidase that is responsible for the adherence to the respiratory tract and facilitates 
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long term infection in cystic fibrosis patients (9). In 
recent epidemiological studies, random amplified polymorphic DNA (RAPD) PCR has been extensively used for molecular characterization of bacteria due to its simplicity, rapidity, sensitivity, reproducibility and low cost. It can determine genetic diversity without 
prior knowledge of the genome under study (10). This study was aimed to investigate the antibiotic resistance 
profiles, prevalence and production of different type of 
β-lactamases (ESBL, AmpC and MBL), class 1 integron, 
and five major virulence genes (exoA, exoS, exoU, pilB, and 
nan1) in clinical isolates of MDR P. aeruginosa collected from four main referral hospitals in Shiraz and Kerman cities, in southeast of Iran. The clonal relationship of the MDR isolates was also determined.
Materials and Methods
Specimen collection
From September 2013 to November 2014, a total of 208 non-duplicate isolates of P. aeruginosa were recovered from inpatients of four main referral hospitals of A (Namazi with 800 beds), B (Faghihi with 400 beds), C (Ghotbeddin with 80 beds) in Shiraz and D (Shafa with 400 beds) in Kerman, Iran. Samples were taken by expert technicians from hospitalized patients admitted to adult ICUs, NICUs, burn, respiratory care units, general medical and surgical wards, emergency and kidney transplantation wards. The sampling procedure from wound included swabs taken from clinically deep areas of the burn wounds. Blood culture was prepared from patients with suspected bacteremia or sepsis and inoculated into BACTEC™ blood culture medium. The other samples were placed in stuart transport medium (Merck, Darmstadt - Germany) and transferred to the 
laboratory for identification by standard microbiological 
tests (11). The bacterial isolates were inoculated into sterile True North TM Cryogenic vials (TNC) containing 
1 ml of sterile tryptic soy broth (TSB) (BioMerieux, Marcy-I’Etoile, France), mixed with glycerol (40%) and stored at -70 °C until further examination (11).
Antimicrobial susceptibility testingKirby–Bauer disk diffusion method was used for antimicrobial susceptibility test as recommended by Clinical and Laboratory Standards Institute guidelines 
(CLSI-2014) (12). All antibiotic disks were purchased from Mast Co Ltd, UK and used as per manufacturer’s instructions. The following disks were used for antibiotic sensitivity assay (µg per disk); amikacin (AK 
30), tobramycin (TN 10), gentamicin (GM 10), cefepime (CPM 30), ceftazidime (CAZ 30), ceftriaxone (CRO 30), 
aztreonam (ATM 30), imipenem (IMI 10), meropenem 
(MEM 10), ciprofloxacin (CIP 5), piperacillin/
tazobactam (PTZ 110), polymyxin B (PB 300 units) and 
colistin (CL 10). Minimum inhibitory concentration (MIC) for imipenem resistance isolates was checked 
by E-strip test (Liofilchem Co., Italy) as CLSI guideline 
(13). P. aeruginosa ATCC 27853 was used as the quality control strain for antimicrobial susceptibility testing throughout this study.
Identification of ESBL and MBL enzymes by phenotypic 
methodsESBL production was determined by double-disk 
synergy test (DDST), according to CLSI guidelines and manufacturer’s protocol (MastTM extended spectrum 
β-lactamase set; CPD10) (12). Cefotaxime (30 μg) and 
ceftazidime (30 μg) disks alone or in combination with 
clavulanic acid (30/10 μg) were used for ESBL detection. 
An increase in zone diameter of ≥5mm around the disks containing clavulanic acid indicated production of ESBL by the test organism. To counteract the effect of high-level expression of the naturally produced 
AmpC-type β-lactamase, double-disk synergy test was 
also performed on cloxacillin (200 μg/ml) containing 
plates (14). Detection of MBL was carried out by MBL-
strips (Liofilchem Co, Italy). Briefly, a strip containing imipenem (4-256 µg) on one side and imipenem+EDTA 
(1-64 µg) on the other side (IMI/IMD) was placed on a Muller Hinton agar plate inoculated with the test organism. The tests were considered positive when 
the ratio of IMI/IMD was ≥ 8 mm. The results were 
confirmed by modified Hodges test (15).
Identification of AmpC by phenotypic methodProduction of AmpC by the isolates was determined using Muller- Hinton agar (BioMerieux, France) plates, inoculated with Esherichia coli ATCC 25922 cefoxitin-susceptible strains. A cefoxitin disk (FOX 30 µg) was 
placed between two blank disks each containing 1:1 
mixture of saline and Tris-EDTA 100 × solutions. The paper blank was inoculated with P. aeruginosa test isolates. Flattening of the growth inhibition zone toward 
the paper disk indicates AmpC production (16).
Detection of MBL resistance genes and class 1 
integron by PCRThe presence of MBL genes, VIM, IMP, NDM and 
class 1 integrons (IntΙ1) was assessed by PCR using 
specific sets of forward and reverse primers, as shown 
in Table 1. The bacterial cells were grown overnight on Luria-Bertani (LB) agar. The whole genomic DNA was 
Table 1. Primers used in present study to detect genes and integrolls 
1 
 
 Target genes Primer sequence (5´→3´) Size (bps) Reference 
exoS F: ATC CTC AGG CGT ACA TCC R: ACG ACG GCT ATC TCT CCA C 328 (17) 
exoU F: GAT TCC ATC ACA GGC TCG R: CTA GCA ATG GCA GTA ATC G 3308 (17) 
pilB F: TCG AAC TGA TGA TCG TGG R: CTT TCG GAG TGA ACA TCG 408 (17) 
nan1 F: ACG CTC CGT CCA GCC GGA R: GTC TGG ACG ACG GCG GCA 221 (18) 
exoA F: GACAACGCCCTCAGCATCACCAGC R: CGCTGGCCCATTCGCTCCAGCGCT 396 (18) 
blaVIM1 F: CCG ATG GTG TTT GGT CGC AT R: GAA TGC GCA GCA CCA GGA 391 (41) 
blaIMP1 F: CTA CCG CAG CAG AGT CTT TG R: AAC CAG TTT TGC CTT ACC AT 587 (41) 
blaNDM F: GGT TTG GCG ATC TGG TTT TC R: CGG AAT GGC TCA TCA CGA TC 621 (42) 
intI1 F: GTT CGG TCA AGG TTC TG R: GCC AAC TTT CAG CAC ATG 923 (41) 
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extracted from single colonies using the DNA genomic 
extraction kit (Thermo Scientific, Vilnius, Lithuania) and 
used as a template for PCR amplification, as described by the manufacturer. PCR reaction mixtures (25 µl) consisted of 2.5 units of Taq DNA polymerase (Thermo 
Scientific Co), 10 pmol of each primer, 1 µl of dNTP mix 
(Thermo Scientific Co), 2 µl of DNA template in the PCR buffer provided by manufacturer (Cinnagen, Iran). DNA 
amplification was conducted in a temperature gradient thermal cycler (Applied Biosystems, 96 well, Veriti, USA). The PCR was as follows; one cycle pre-denaturation at 94 °C for 5 min, 35 cycles of denaturation at 94 °C for 30 sec, annealing at 55 °C for 30 sec (for int1and blaIMP-1 gene temperature was 50 °C), and extension at 72 °C for 30 sec 
followed by a final extension at 72 °C for 10 min. PCR 
products (10 µl ) were subjected to gel electrophoresis 
using 1% agarose gel (Merck, Germany) for 1 hr, stained with UV illuminating dye (Gel Red) and visualized by a UV-gel documentation system (Gel logic200, Kodak, 
USA) (17).
Detection of major virulence genes by PCRIndividual colonies of P. aeruginosa isolates were used for detection of exoA, exoS, exoU, pilB, and nan1 
genes using the primers listed in Table 1, as described 
previously (9, 17, 18).
Clonal relationships among MDR isolates by RAPD-PCRRAPD-PCR was used RAPD primers 208 (5´-ACGGCCGACC-3´) and 272 (5´- AGCGGGCCAA- 3´), 
as described earlier (19). The amplification protocol 
consisted of 25 µl RAPD- PCR mixture buffer (10 mM Tris/HCl, 50 mM KCl, 2.5 mM MgCl2, pH 8.3) containing 
250 µM of each dNTP, 40 pmol oligonucleotide, 1 U Taq DNA polymerase Invitrogen (Invitrogen, CA, USA) and 40 ng template DNA. A negative control contained all the components except template DNA. PCR products were 
separated in 1.5% agarose gels and the resulting band patterns were analyzed using unweighted pair-group method with arithmetic averages (UPGMA) clustering (Gel Compare II software, version 4.0, Applied Maths, Sint-Matenslatem, Belgium). Isolates with 96% or greater similarity were considered as identical, and a cut-off value of 80% similarity was used for clustering.
Statistical analysesAll analyses were performed using SPSS, version 
16.0 (SPSS Inc, Chicago, IL, USA, 2014). Chi-square test was used to investigate the differences between distributions of categorical data. Two-tailed; P-values of 
≤ 0.05 were considered statistically significant.
Results
Sample sources and antibiotic susceptibility
One hundred isolates were from hospital A (31% from urine as the most frequent), 55 from hospital B (44% from sputum of patients with respiratory tract infection as the most frequent), 27 were from hospital C (all from burn exudates) and 26 from hospital D (all from burn 
exudates) and antibacterial susceptibility profiles of the 
P. aeruginosa isolates to 13 antibiotics are presented in Table 2. All isolates were susceptible to polymyxin B and colistin. Overall, 40.4% (n=84) of the isolates were MDR and 40% were carbapenem-resistant. From 84 MDRPA 
isolates, 53 (63%) were resistant to 11 antibiotics, of which 36 isolates were recovered from burn exudates. The rate of MDR P. aeruginosa (defined as resistance to at least 3 antibiotic classes) was 40.4% (in 208 isolates), including 68% from burn exudates, 37.5%, from urinary 
tract infection and 17.4% from blood samples. 
Prevalence of AmpC, ESBL, MBL and class 1 integronsThe rates of ESBL, AmpC and MBL production among the MDRPA are shown in Table 3. The highest rate of AmpC production was detected in isolates recovered 
from burn exudates of hospitals C and D (n=18, 50%). MBL activity was detected in 64.3% (n=54) of the MDR isolates, and bla
IMP-1 
and blaVIM genes were detected 
in 84.5% (n=71) and 4.8% (n=4) of these isolates, respectively. No blaNDM was detected in this study. In 
addition, class 1 integrons was detected in 95% (n= 80) of the MDR isolates.
Detection of virulence genesThe exoA gene was detected in all 208 isolates and was the most frequent gene in both MDR and non MDR 
P. aeruginosa isolates with a total frequency of 98.8% and 93.5%, respectively. The second most frequent virulence gene in the 84 MDR isolates was exoS (44%), 
Table 2. Antibiotic resistant profile of Pseudomonas aeruginosa collected from hospitalized patients of four hospitals in Iran based on source of isolation
Amikacin (AK), Tobramycin (TN), Gentamicin (GM), cefepime (CPM), ceftazidime (CAZ), ceftriaxone (CRO), aztreonam (ATM), imipenem (IMI), 
meropenem (MEM), ciprofloxacin (CIP), piperacillin/tazobactam (PTZ)
2 
 
 
Source      Number of isolate Number (%) resistant isolates PTZ CIP MEM IMI ATM CRO CAZ CPM GM TN AK 
Burn exudate 53 37(69.8) 34(64.15) 36(67.92) 35(66.03) 41(77.35) 41(77.35) 31(58.49) 37(69.81) 35(66.03) 35(66.03) 33(62.26) Urine 48 12(25) 16(33.33) 17(35.41) 17(35.41) 14(29.16) 30(62.50) 13(27.08) 13(27.08) 17(35.41) 15(31.25) 13(27.08) Sputum 29 7(24.13) 9(31.03) 11(37.93) 10(34.48) 8(27.58) 18(62.06) 8(27) 8(27.58) 8(27.58) 7(24.13) 6(20.68) Blood 23 4(17.39) 1(4.34) 4(17.39) 3(13.04) 4(17.39) 12(52.17) 3(13.04) 4(17.39) 4(17.39) 2(8.69) 1(4.34) Wound 22 3(13.63) 6(27.27) 5(22.72) 5(22.72) 7(31.81) 14(63.63) 6(27.27) 5(2.72) 5(22.72) 5(22.72) 5(22.72) Eye 14 1(7.14) 1(7.14) 6(42.85) 5(35.71) 5(35.71) 8(57.14) 1(7.14) 1(7.14) 1(7.14) 1(7.14) 1(7.14) Others 19 2(10.52) 3(15.78) 7(36.84) 7(36.84) 5(26.31) 11(57.89) 2(10.52) 3(15.78) 3(15.78) 2(10.52) 3(15.78) Total 208 66(31.73) 70(33.65) 86(41.34) 82(39.42) 84(40.38) 134(64.42) 64(30.76) 71(34.13) 73(35.09) 67(32.21) 62(29.80)   
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followed by nan1 (33.3%), exoU (26%) and pilB (8.3%) 
(Figures 1 and 2).
Clonality relationship among P. aeruginosa MDR 
isolates
Based on RAPD-PCR profiles, the number of bands 
ranged from 10 to 19 with sized from 200–2000 bps. 
As shown in Figure3, four clusters were identified 80% similarity with 95% identical band patterns, indicating similar genetic backgrounds. We also found two small clusters (two member isolates) and three singletons. 
Most of the cluster 1 isolates were from hospital D in Kerman and most of cluster 2 isolates were recovered 
from hospitals A (36%), B (50 %) and C (14 %) in Shiraz.
DiscussionMDRPA has emerged as one of the most frequently observed nosocomial infectious agents causing a high rate of mortality among hospitalized patients (20). 
Table 3. Prevalence of multi-drug resistance, β-lactamases production and class 1 integron among Pseudomonas aeruginosa from hospitalized patients of four hospitals of Iran 
MDR= multidrug-resistant, MBL= metallo-β-lactamase, ESBL= extended spectrum-β-lactamase, IMI= imipenem, intΙ1= class 1 integrons integrase gene. Value in bracket indicate % in MDR population.*.NDM gene was not detected in any isolate. Others = fluids/c, Nose/c, etc
Figure 1. Agarose gel electrophoresis of PCR products of virulent genes
M: marker (100 bp); NC: negative control; PC: positive control
 
 
 
 
 
 
 
 
Figure 2. Distribution of exoS, exoU, pilB, nan1 and exoA genes among hospital isolates of MDR Pseudomonas aeruginosa from four hospitals in southeast of Iran. The error bar indicates average of three independent experiments
 
Figure 3. Clonal relationships among Pseudomonas aeruginosa isolates recovered from hospitals in two geographic locations in Iran 
shown by RAPD-PCR fingerprints. Banding patterns were analyzed by the unweighted pair-group method with arithmetic averages (UPGMA) clustering using Gel Compare II software, version 4.0 (Applied Maths, Sint-Matenslatem, Belgium). The vertical lines show 80% similarity cut-off. *N= Namazi, F= Faghihi. G= Ghotbeddin (Shiraz, Iran) and Sh= Shafa hospitals (Kerman, Iran)
Source/Samples Number of isolates % MDR ESBL MBL (in MDRPA) AmpC IMI mean MIC (µg/ml) (E-test) 
*MBL genes intΙI 
IMP-1 VIM  
Burn exudate 53 36(68) 46(86.8) 32(89.9) 18(50) 64 29(80) 4(11) 36(100) 
Urine 48 18(37.5) 32(66.7) 9(50) 5(27.7) 64 14(77)  18(100) 
Sputum 29 11(38) 20(69) 6(54.5) 1(9.1) 128 10(90) - 8(72) 
Blood 23 4(17.4) 12(52) 1(25) - 32 4(100) - 4(100) 
Wound 22 6(27.3) 15(68) 2(33.3) 3(50) 64 6(100) - 6(100) 
Eye 14 3(21.5) 6(42.8) 3(50) 1(33.3) 64 3(100) - 3(100) 
Others 19 6(31.5) 14(73.7) 1(16.7) - 32 5(83) - 5(83) 
Total 208 84(40.4) 145(70) 54(64.3) 28(33) - 71(84.5) 4(4.8) 80(95.2) 
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According to European Centre for Disease Prevention 
and Control 2012, point prevalence survey of healthcare-associated infections, it accounted for 8.9% 
of nosocomial infections, and 17.4% of lower respiratory 
tract infections in European acute care hospitals (21).In the present study, and the rate of MDR P. aeruginosa was 40.4% and was highest in the isolates obtained from burn exudates (68%), followed by urinary tract 
infection isolates (37.5%) and blood samples (17.4%). A report from a surveillance study of 65 laboratories in 
the United States (1998 to 2001) showed that 7.0% of clinical isolates of P. aeruginosa from non-ICU patients 
and 9.1% of isolates from ICU patients were MDR. In another surveillance study conducted on MDRPA in an urban tertiary-care teaching hospital in USA in 2002, it was shown that the rate of MDR was 32% and increased 
by more than 20% over a five-year period (22). In another investigation in a tertiary care hospital in India 
from February 2012 to January 2013, the rate of MDRPA 
was 41.3% which is similar to our results (23). Overall, the rates of resistance of our isolates recovered from 
burn exudates were significantly higher than that of the other sources (P<0.05). Similar rates have been reported from other centers in Iran including 45.3% among burn 
patients studied in 2012 in Guilan by Nikokar et al. (24), and 45% by Fazeli et al. (25) in 2017 from patients at the university teaching hospital in Iran. Higher rates of 
MDRPA were reported by Yousefi et al. (2011-2012) in Shiraz (62.8%) and Ghanbarzadeh et al. (2015) from a 
single center for burn patients in Tehran, Iran (93.1%) (26, 27).In our study, burn isolates exhibited the highest degree of resistance (>60%) to 11 antibiotics compared to the isolates from other sources (Table 2). Imipenem 
resistance was detected in 84.5% of (71 out of 84) MDRPA isolates and 39% (82 out of 208) of all P. 
aeruginosa isolates. As observed, compared to the isolates from other sources MDRPA isolated from burn exudates had the highest rate of ESBL (86.8%), MBL (89.8%) and AmpC (50%) production (Table 3).In a report from burn patients in Hospital C in 2006, 
the rate of ESBL production was 4.3%, AmpC was 11.4% and MBL was 0% (28). Excessive use of antibiotics could be associated with the development of more resistant strains as a result of and horizontal gene spread. High frequencies of ESBL production in P. aeruginosa isolates from burn patients were reported from Iran 
by Rafiee et al. (39.2% ESBL, 37.3% MBL, and 68.6% 
AmpC production among 51 MDRPA isolates) (29). In 
a research carried out by Salimi and Eftekhar on 128 imipenem-resistant isolates of P. aeruginosa in Tehran, 
Iran, 12.5% were capable of producing ESBL, 25% MBL, 
and 81% produced AmpC β-lactamases (30). MBL blaVIM and bla
IMP-1
 genes are the common in MDR isolates of P. 
aeruginosa in Iran (31-33). The rate of bla
IMP-1
 gene in our study was higher than those reported from other parts of Iran. Also, 95.2% of our MDRPA isolates had 
IntI1 gene which is similar with the study of Khosravi 
et al. from Ahvaz and Yousefi et al. from Tehran (6, 34). However, lower rate of IntI1 gene were reported in 
other parts of Iran (1, 24, 34). Investigating the three MBL genes, blaVIM, blaIMP-1 and blaNDM among MDRPA strains, revealed that all imipenem-resistant isolates 
harbored bla
IMP-1
 gene. The common MBL genes in Asia are blaVIM and blaIMP-1 (31). A higher rate of blaIMP-1 gene was detected in the present study in comparison with other Iranian studies: Shahcheraghi et al. 0% in 2010, Kalanter et al. 3% in 2011 and 2012, and Sarhangi et al. 
9.75% in 2012 (31, 35, 36). The rate of blaVIM gene was 4.8% detected in 4 MDRPA strains isolated from burn 
exudates, higher than similar studies from Iran (31, 37). 
In addition, recently our group identified one strain of 
P. aeruginosa harboring the blaNDM gene in Kerman, Iran (unpublished result).Presence of diverse virulence genes in P. aeruginosa hospital isolates has been shown to associate with the intensity and severity of infections (38). The high worldwide prevalence of exotoxin A in P. aeruginosa 
has resulted in its use for identification of clinical isolates (39). The prevalence rates of exoS and nan1 
genes were significantly higher in burn exudates (50% for exoS and 47% for nan1, respectively) than in other samples (P=0.0001). In contrast, the prevalence of exoU 
gene was significantly lower in burn exudate (16%) (P=0.023). The least virulence gene detected in this study was pilB (n=7, 8.3%), similar in burn exudates and non-burn samples. The higher frequency of nan1in burn patients may be due to its neuraminidase activity which facilitates bacterial attachment to the epithelial surfaces of burns and airways of cystic fibrosis patients resulting in colonization of P. aeruginosa (38).There are few reports about clonal relationship among hospital isolates of P. aeruginosa in Iran. Our analysis of RAPD data showed four large clusters consisting 
of 77 isolates out of 84 (91.7%). We also detected the 
aggregation of isolates related to specific clusters in different hospitals (Figure 3). The high genetic similarity among MDRPA isolates suggests the cross-acquisition of infection. The dendrogram analysis revealed that cluster 
3 exhibited the largest fingerprint similarity consisting of 29 isolates. Among the cluster 3 isolates, 76% were 
from hospital A and 21% from hospital C (Figure 3). Members of this cluster demonstrated close genetic relationships compared to other clusters, suggesting the possible spread of cluster 3 clones in different wards of hospitals A and C in Shiraz. Most members of cluster 4 were from hospitals B and C. As presented in Figure 
3, all singletons showed resistance to 11 antibiotics, simultaneously.Taheri et al. studied the genetic similarity among 73 
P. aeruginosa isolates from Tehran referral hospitals by RAPD patterns and showed 67 different patterns, each containing 2-3 isolates, mostly from ICU (40). They concluded that most of the isolates were probably originated from the host.
ConclusionBased on the results, it can be concluded that our 
P. aeruginosa hospital isolates are highly resistant to different classes of antibiotics and sensitive to colistin and polymyxin B, which could be used as an empirical therapy in critically ill patients, especially in burn patients and those admitted to ICU. High genetic similarity among MDRPA isolates indicates cross-acquisition of infection, suggesting the importance of infection control in decreasing the prevalence of MDRPA in hospitals.
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